Managing rhinitis: Strategies for improved patient outcomes

Authors: Carr, Warner W.¹; Nelson, Michael R.²; Hadley, James A.³

Source: Allergy and Asthma Proceedings, Volume 29, Number 4, July-August 2008 , pp. 349-357(9)

Publisher: OceanSide Publications, Inc

Free trial available!

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Allergic rhinitis affects more than 40 million Americans, with estimated costs reaching $5.3 billion annually. The global impact includes negative effects on quality of life (QOL), sleep, diminished work productivity, and exacerbation of comorbid conditions. An accurate diagnosis of allergic or nonallergic rhinitis is needed before selecting optimal treatment, which can include antihistamines, decongestants, intranasal corticosteroids, immunotherapy, and anticholinergics. It is also important to understand that pharmacologic properties of these different interventions may affect patient satisfaction, compliance, and overall clinical response. This article reviews currently available therapies for allergic rhinitis with a focus on improving patient outcomes.

Keywords: Allergens; allergic rhinitis; anticholinergics; antihistamines; congestion; decongestants; immunotherapy; intranasal corticosteroids; nonallergic rhinitis; vasomotor rhinitis

Document Type: Research article

DOI: 10.2500/aap.2008.29.3145

Affiliations: 1: Allergy and Asthma Associates of Southern California, Mission Viejo, California 2: Department of Allergy-Immunology, Walter Reed Army Hospital, Department of Allergy, Washington, DC 3: Otolaryngology-Head & Neck Surgery (per Hadley), University of Rochester Medical Center, Rochester, New York

Free content The full text is free.

View now: